UniProtKB/Swiss-Prot P06307: Variant p.Arg95Trp

Cholecystokinin
Gene: CCK
Feedback?

Variant information Variant position:

95 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Tryptophan (W) at position 95 (R95W, p.Arg95Trp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to large size and aromatic (W) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs3774395 [ dbSNP | Ensembl ]

Sequence information Variant position:

95 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

115 The length of the canonical sequence.
Location on the sequence:

GRMSIVKNLQNLDPSHRISD R DYMGWMDFGRRSAEEYEYPS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GRMSIVKN-LQNLDPSHRISDRDYMGWMDFGRRSAEEYEYPS

                              GRMSVIKN-LQNLDPSHRISDRDYMGWMDF-----------

Mouse                         GRMSVLKN-LQSLDPSHRISDRDYMGWMDFGRRSAEDYEYP

Rat                           GRMSVLKN-LQGLDPSHRISDRDYMGWMDFGRRSAEDYEYP

Pig                           GRVSMIKN-LQSLDPSHRISDRDYMGWMDFGRRSAEEYEYT

Bovine                        GRMSVIKN-LQSLDPSHRISDRDYMGWMDFGRRSAEEFEYT

Chicken                       GRFSVLGNRVQSIDPTHRINDRDYMGWMDFGRRSAEEYEYS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	21 – 115	Cholecystokinin
Peptide	46 – 103	Cholecystokinin-58
Peptide	65 – 103	Cholecystokinin-39
Peptide	71 – 103	Cholecystokinin-33
Peptide	79 – 103	Cholecystokinin-25
Peptide	86 – 103	Cholecystokinin-18
Peptide	92 – 103	Cholecystokinin-12
Modified residue	97 – 97	Sulfotyrosine
Modified residue	103 – 103	Phenylalanine amide
Modified residue	111 – 111	Sulfotyrosine
Modified residue	113 – 113	Sulfotyrosine
Mutagenesis	97 – 97	Y -> F. Reduces the quantity of secreted CCK8 by 50%.

Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.